APA (7th ed.) Citation

C, F., E, L., J, D., S, C., B, M., JM, B., . . . G, L. (2026). Dissecting residual disease in spheroids reveals pan-cancer persistence signatures and a therapeutic window for oncolytic viruses. Molecular therapy. Oncology, 34(3), 201279. https://doi.org/10.1016/j.omton.2026.201279

Chicago Style (17th ed.) Citation

C, Fauveau, Lawendy E, Deforges J, Cochin S, Moreau B, Balloul JM, Erbs P, Jain S, and Laverny G. "Dissecting Residual Disease in Spheroids Reveals Pan-cancer Persistence Signatures and a Therapeutic Window for Oncolytic Viruses." Molecular Therapy. Oncology 34, no. 3 (2026): 201279. https://doi.org/10.1016/j.omton.2026.201279.

MLA (9th ed.) Citation

C, Fauveau, et al. "Dissecting Residual Disease in Spheroids Reveals Pan-cancer Persistence Signatures and a Therapeutic Window for Oncolytic Viruses." Molecular Therapy. Oncology, vol. 34, no. 3, 2026, p. 201279, https://doi.org/10.1016/j.omton.2026.201279.